{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:31:37Z","timestamp":1784194297794,"version":"3.55.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.1093\/cid\/cir239","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T01:03:37Z","timestamp":1305767017000},"page":"1384-1387","source":"Crossref","is-referenced-by-count":16,"title":["Poor Prognosis of HIV-Associated Tuberculous Meningitis Regardless of the Timing of Antiretroviral Therapy"],"prefix":"10.1093","volume":"52","author":[{"given":"Stephen D.","family":"Lawn","sequence":"first","affiliation":[{"name":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"},{"name":"Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[{"name":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"2019091011374755700_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COH.0b013e32832c7d61","article-title":"Epidemiology of HIV-associated tuberculosis","volume":"4","author":"Lawn","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"2019091011374755700_bib2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(10)60409-6","article-title":"The HIV-associated tuberculosis epidemic\u2013when will we act?","volume":"375","author":"Harries","year":"2010","journal-title":"Lancet"},{"key":"2019091011374755700_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2009.08.010","article-title":"Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings","volume":"30","author":"Lawn","year":"2009","journal-title":"Clin Chest Med"},{"key":"2019091011374755700_bib4","first-page":"6","article-title":"Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa","volume":"13","author":"Harries","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019091011374755700_bib5","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"2019091011374755700_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/QCO.0b013e3283420f76","article-title":"Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections","volume":"24","author":"Lawn","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"2019091011374755700_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/QAI.0b013e3181398d28","article-title":"Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answer","volume":"46","author":"Lawn","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019091011374755700_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis-coinfected patients with and without antiretroviral therapy","volume":"43","author":"Manosuthi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019091011374755700_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31819367e7","article-title":"Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis","volume":"50","author":"Velasco","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019091011374755700_bib10","article-title":"Significant enhancement in survival with early (2 weeks) vs late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis (abstract THLBB1)","volume-title":"Program and abstracts of the XVIII International AIDS Conference","author":"Blanc","year":"2010"},{"key":"2019091011374755700_bib11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"2019091011374755700_bib12","volume-title":"Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a publc health approach (2010 revision)","author":"World Health Organization"},{"key":"2019091011374755700_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cir230","article-title":"Timing of initiation of antiretroviral therapy in human immunodeficiency virus-associated tuberculous meningitis","author":"T\u00f6r\u00f6k","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2019091011374755700_bib14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(06)69117-4","article-title":"Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study","volume":"368","author":"Badri","year":"2006","journal-title":"Lancet"},{"key":"2019091011374755700_bib15","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"2019091011374755700_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328321823f","article-title":"Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"2019091011374755700_bib17","doi-asserted-by":"crossref","first-page":"e1772","DOI":"10.1371\/journal.pone.0001772","article-title":"Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults","volume":"3","author":"Torok","year":"2008","journal-title":"PLoS One"},{"key":"2019091011374755700_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"2019091011374755700_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/430616","article-title":"Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis","volume":"192","author":"Thwaites","year":"2005","journal-title":"J Infect Dis"},{"key":"2019091011374755700_bib20","doi-asserted-by":"crossref","first-page":"c4451","DOI":"10.1136\/bmj.c4451","article-title":"Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study","volume":"341","author":"Vinnard","year":"2010","journal-title":"BMJ"},{"key":"2019091011374755700_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"2019091011374755700_bib22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/COH.0b013e328302ebd1","article-title":"Immune reconstitution disease of the central nervous system","volume":"3","author":"Torok","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"2019091011374755700_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"2019091011374755700_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0b013e328333850f","article-title":"Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings","volume":"5","author":"Lawn","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"2019091011374755700_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources","volume":"10","author":"Lawn","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2019091011374755700_bib26","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":"Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS One"},{"key":"2019091011374755700_bib27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa","volume":"50","author":"Makadzange","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/52\/11\/1384\/29578820\/cir239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T12:00:22Z","timestamp":1568116822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/52\/11\/1384\/409402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cir239","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,6,1]]},"published":{"date-parts":[[2011,6,1]]}}}